Epigenetic Regulation of Hepatocellular Carcinoma Progression through the mTOR Signaling Pathway
Canadian Journal of Gastroenterology and Hepatology · 2021-01 · 2021 (1)
DOI: 10.1155/2021/5596712 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Canadian Journal of Gastroenterology and Hepatology, online erschienen am 25.05.2021. Verfasst von Mengnan Guo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Tangshan Maternal and Child Health Care Hospital, North China University of Science and Technology, Tangshan 063000, Hebei, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hebei Province, Department of Education of Hebei Province.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, is an aggressive tumor with a high mortality rate because of the limited systemic and locoregional treatment modalities. The development and progression of HCC depend on epigenetic changes that result in the activation or inhibition of some signaling pathways. The mTOR signaling pathway is essential for many pathophysiological processes and is considered a major regulator of cancer. Increasing evidence has shown that epigenetics plays a key role in HCC biology by regulating the mTOR signaling pathway. Therefore, epigenetic regulation through the mTOR signaling pathway to diagnose and treat HCC will become a very promising strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Tangshan Maternal and Child Health Care Hospital, North China University of Science and Technology, Tangshan 063000, Hebei, China.
- North China University of Science and Technology Affiliated Hospital, Tangshan 063000, Hebei, China.
ORCID-Profile: Mengnan Guo, Jinghua Wu
Förderung
- Natural Science Foundation of Hebei Province
- Department of Education of Hebei Province
Zitieren
APA
Guo, M., Li, N., Zheng, J., Wang, W., Wu, Y., Han, X., Guo, J., Chen, W., Bai, Z., Bai, W., & Wu, J. (2021). Epigenetic Regulation of Hepatocellular Carcinoma Progression through the mTOR Signaling Pathway. Canadian Journal of Gastroenterology and Hepatology, 2021(1). https://doi.org/10.1155/2021/5596712
Vancouver
Guo M, Li N, Zheng J, Wang W, Wu Y, Han X, et al. Epigenetic Regulation of Hepatocellular Carcinoma Progression through the mTOR Signaling Pathway. Canadian Journal of Gastroenterology and Hepatology. 2021;2021(1). doi:10.1155/2021/5596712
BibTeX
@article{Guo2021,
author = {Guo, Mengnan and Li, Ning and Zheng, Jianxia and Wang, Wei and Wu, Yan and Han, Xu and Guo, Jiapei and Chen, Weixi and Bai, Zekun and Bai, Wen and Wu, Jinghua},
title = {Epigenetic Regulation of Hepatocellular Carcinoma Progression through the mTOR Signaling Pathway},
journal = {Canadian Journal of Gastroenterology and Hepatology},
year = {2021},
volume = {2021},
number = {1},
doi = {10.1155/2021/5596712}
}
EUVIMED